These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 30239624)

  • 1. Clinical Effectiveness of Influenza Vaccination After Allogeneic Hematopoietic Stem Cell Transplantation: A Cross-sectional, Prospective, Observational Study.
    Piñana JL; Pérez A; Montoro J; Giménez E; Gómez MD; Lorenzo I; Madrid S; González EM; Vinuesa V; Hernández-Boluda JC; Salavert M; Sanz G; Solano C; Sanz J; Navarro D
    Clin Infect Dis; 2019 May; 68(11):1894-1903. PubMed ID: 30239624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seasonal Human Coronavirus Respiratory Tract Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation.
    Piñana JL; Xhaard A; Tridello G; Passweg J; Kozijn A; Polverelli N; Heras I; Perez A; Sanz J; Berghuis D; Vázquez L; Suárez-Lledó M; Itäla-Remes M; Ozcelik T; Iturrate Basarán I; Karakukcu M; Al Zahrani M; Choi G; Cuesta Casas MA; Batlle Massana M; Viviana A; Blijlevens N; Ganser A; Kuskonmaz B; Labussière-Wallet H; Shaw PJ; Yegin ZA; González-Vicent M; Rocha V; Ferster A; Knelange N; Navarro D; Mikulska M; de la Camara R; Styczynski J
    J Infect Dis; 2021 May; 223(9):1564-1575. PubMed ID: 32860509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence, risk factors, and outcome of pulmonary invasive fungal disease after respiratory virus infection in allogeneic hematopoietic stem cell transplantation recipients.
    Piñana JL; Gómez MD; Montoro J; Lorenzo I; Pérez A; Giménez E; González-Barberá EM; Carretero C; Guerreiro M; Salavert M; Sanz G; Hernández-Boluda JC; Borrás R; Sanz J; Solano C; Navarro D
    Transpl Infect Dis; 2019 Oct; 21(5):e13158. PubMed ID: 31402532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Respiratory virus infection after allogeneic hematopoietic stem cell transplant in a tropical center: Predictive value of the immunodeficiency scoring index.
    Wang L; Allen J; Diong C; Goh YT; Gopalakrishnan S; Ho A; Hwang W; Lim F; Oon L; Tan TT; Linn YC; Tan BH
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28295964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of virosomal adjuvanted trivalent influenza vaccination in allogeneic stem cell transplant recipients.
    Ambati A; Einarsdottir S; Magalhaes I; Poiret T; Bodenstein R; LeBlanc K; Brune M; Maeurer M; Ljungman P
    Transpl Infect Dis; 2015 Jun; 17(3):371-9. PubMed ID: 25817044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significant Transplantation-Related Mortality from Respiratory Virus Infections within the First One Hundred Days in Children after Hematopoietic Stem Cell Transplantation.
    Hutspardol S; Essa M; Richardson S; Schechter T; Ali M; Krueger J; Fujii H; Egeler RM; Gassas A
    Biol Blood Marrow Transplant; 2015 Oct; 21(10):1802-7. PubMed ID: 26117558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiologic and Clinical Characteristics of Coronavirus and Bocavirus Respiratory Infections after Allogeneic Stem Cell Transplantation: A Prospective Single-Center Study.
    Piñana JL; Madrid S; Pérez A; Hernández-Boluda JC; Giménez E; Terol MJ; Calabuig M; Navarro D; Solano C
    Biol Blood Marrow Transplant; 2018 Mar; 24(3):563-570. PubMed ID: 29155041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum IgM levels independently predict immune response to influenza vaccine in long-term survivors vaccinated at >1 year after undergoing allogeneic hematopoietic stem cell transplantation.
    Fukatsu Y; Nagata Y; Adachi M; Yagyu T; Ono T
    Int J Hematol; 2017 May; 105(5):638-645. PubMed ID: 27943117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary Impairment after Respiratory Viral Infections Is Associated with High Mortality in Allogeneic Hematopoietic Cell Transplant Recipients.
    Sheshadri A; Chemaly RF; Alousi AM; Shah PK; Rondon G; Bashoura L; Kmeid J; Azzi J; Blanco DW; Kaous M; Dickey BF; Champlin RE; Shah DP
    Biol Blood Marrow Transplant; 2019 Apr; 25(4):800-809. PubMed ID: 30521974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for lower respiratory tract disease and outcomes in allogeneic hematopoietic stem cell transplantation recipients with influenza virus infection.
    Shiraiwa S; Harada K; Onizuka M; Kawakami S; Hara R; Aoyama Y; Amaki J; Ogiya D; Suzuki R; Toyosaki M; Machida S; Omachi K; Kawada H; Ogawa Y; Ando K
    J Infect Chemother; 2022 Sep; 28(9):1279-1285. PubMed ID: 35691863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of immunodeficiency scoring index performance in enterovirus/rhinovirus respiratory infection after allogeneic hematopoietic stem cell transplantation.
    Pérez A; Montoro J; Hernani R; Lorenzo I; Hernández-Boluda JC; Giménez E; Gómez MD; Balaguer-Roselló A; Gonzalez-Barberá E; Guerreiro M; Aguilar C; Navarro D; Solano C; Sanz J; Piñana JL
    Transpl Infect Dis; 2020 Aug; 22(4):e13301. PubMed ID: 32363665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The humoral immune response of hematopoietic stem cell transplantation recipients to AS03-adjuvanted A/California/7/2009 (H1N1)v-like virus vaccine during the 2009 pandemic.
    Engelhard D; Zakay-Rones Z; Shapira MY; Resnick I; Averbuch D; Grisariu S; Dray L; Djian E; Strauss-Liviatan N; Grotto I; Wolf DG; Or R
    Vaccine; 2011 Feb; 29(9):1777-82. PubMed ID: 21216315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical benefit of instituting a prospective clinical community-acquired respiratory virus surveillance program in allogeneic hematopoietic stem cell transplantation.
    Piñana J; Montoro J; Aznar C; Lorenzo I; Gómez MD; Guerreiro M; Carretero C; González-Barberá EM; Balaguer-Roselló A; Sanz R; Salavert M; Navarro D; Sanz MA; Sanz G; Sanz J
    J Infect; 2020 Mar; 80(3):333-341. PubMed ID: 31972212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sociodemographic and psychological determinants of influenza vaccine intention among recipients of autologous and allogeneic haematopoietic stem cell transplant: a cross-sectional survey of UK transplant recipients using a modified health belief model.
    Miller PDE; Forster AS; de Silva TI; Leonard H; Anthias C; Mayhew M; Klammer M; Paskar S; Hurst E; Peggs K; Madrigal A; Snowden JA
    BMJ Open; 2018 Aug; 8(8):e021222. PubMed ID: 30093515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of community-acquired respiratory viruses infections except seasonal influenza in transplant recipients and non-transplant critically ill patients.
    Lee KH; Yoo SG; Cho Y; Kwon DE; La Y; Han SH; Kim MS; Choi JS; Kim SI; Kim YS; Min YH; Cheong JW; Kim JS; Song YG
    J Microbiol Immunol Infect; 2021 Apr; 54(2):253-260. PubMed ID: 31262511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Multicenter Consortium to Define the Epidemiology and Outcomes of Inpatient Respiratory Viral Infections in Pediatric Hematopoietic Stem Cell Transplant Recipients.
    Fisher BT; Danziger-Isakov L; Sweet LR; Munoz FM; Maron G; Tuomanen E; Murray A; Englund JA; Dulek D; Halasa N; Green M; Michaels MG; Madan RP; Herold BC; Steinbach WJ
    J Pediatric Infect Dis Soc; 2018 Dec; 7(4):275-282. PubMed ID: 29106589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical implications of respiratory virus infections in solid organ transplant recipients: a prospective study.
    López-Medrano F; Aguado JM; Lizasoain M; Folgueira D; Juan RS; Díaz-Pedroche C; Lumbreras C; Morales JM; Delgado JF; Moreno-González E
    Transplantation; 2007 Oct; 84(7):851-6. PubMed ID: 17984837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic Exposure Prior to Respiratory Viral Infection Is Associated with Progression to Lower Respiratory Tract Disease in Allogeneic Hematopoietic Cell Transplant Recipients.
    Ogimi C; Krantz EM; Golob JL; Waghmare A; Liu C; Leisenring WM; Woodard CR; Marquis S; Kuypers JM; Jerome KR; Pergam SA; Fredricks DN; Sorror ML; Englund JA; Boeckh M
    Biol Blood Marrow Transplant; 2018 Nov; 24(11):2293-2301. PubMed ID: 29777867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community-acquired respiratory virus lower respiratory tract disease in allogeneic stem cell transplantation recipient: Risk factors and mortality from pulmonary virus-bacterial mixed infections.
    Piñana JL; Gómez MD; Pérez A; Madrid S; Balaguer-Roselló A; Giménez E; Montoro J; González EM; Vinuesa V; Moles P; Hernández-Boluda JC; Salavert M; Calabuig M; Sanz G; Solano C; Sanz J; Navarro D
    Transpl Infect Dis; 2018 Aug; 20(4):e12926. PubMed ID: 29809298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination against pandemic H1N1 (2009) in patients after allogeneic hematopoietic stem cell transplantation: a retrospective analysis.
    Roll D; Ammer J; Holler B; Salzberger B; Schweiger B; Jilg W; Andreesen R; Edinger M; Wolff D; Holler E
    Infection; 2012 Apr; 40(2):153-61. PubMed ID: 22038110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.